On the morning of June 16, a delegation led by Pan Youchang, Chairman of Beijing Panbao Biotechnology Group Co., Ltd., along with President Li Manjuan and General Manager Qin, visited Hebei Panbao Youqing Technology Co., Ltd. to discuss and provide guidance on operational matters. They held in-depth discussions with factory managers General Manager Wang and General Manager Zhang regarding production operations and key work plans for the second half of the year, establishing comprehensive coordination measures.
As a key component of Panbao Group's bioenzyme industry ecosystem, Hebei Panbao Youqing Technology Co., Ltd.' s Zhuolu 343 Bioenzyme Production Base is responsible for developing, commercializing, and scaling up the group's core bioenzyme products. It continuously advances process optimization and production capacity enhancement in microbial fermentation and composite microbial community applications, serving as a pivotal support unit within the group's biomanufacturing and eco-technology value chain. The seminar focused on factory operational efficiency, process refinement, market collaboration, and progress toward key tasks for the second half of the year, providing a comprehensive review and phased assessment of the stability and scalability of the bioenzyme production system.
During the meeting, all parties conducted in-depth discussions on standardizing production systems, enhancing supply chain coordination efficiency, and expanding the applications of bioenzyme products across various scenarios—including agricultural cultivation, environmental remediation, and resource recycling. They reached a consensus on production plans for the second half of the year and the optimization of collaborative mechanisms.
Going forward, Panbao Group will continue to enhance its integrated management capabilities for core production bases, accelerate the large-scale application of bioenzyme technology in agriculture, environmental governance, and resource recycling, further refine its end-to-end industrial chain spanning R&D, production, and application, and improve overall industrial synergy efficiency and market service capabilities. Simultaneously, the group will maintain technological innovation as its primary driver, steadily advance the upgrading of its biomanufacturing industry layout, strengthen the foundation for core technology commercialization, and continuously inject high-quality momentum into the development of green agriculture and ecological protection industries.